Paul Brent Ferrell Jr. MD

Hematologic Oncology

Physician

Education & Training

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2015
Vanderbilt University Medical CenterResidency, Internal Medicine, 2009 - 2011
University of North Carolina at Chapel Hill School of MedicineClass of 2009

PubMed

2 citations
Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesis.
Taralynn Mack, Yash Pershad, Caitlyn Vlasschaert, Cosmin A Bejan, Jonathan Brett Heimlich
Haematologica. 2025-04-01
18 citations
Apoptolidin family glycomacrolides target leukemia through inhibition of ATP synthase.
Benjamin J. Reisman, Hui Guo, Haley E. Ramsey, Madison T. Wright, Bradley I. Reinfeld
Nature Chemical Biology. 2021-12-02
5 citations
Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemia.
Kathryn I. Sunthankar, Matthew T. Jenkins, Candace H. Cote, Sweta B. Patel, Robert S. Welner
Leukemia. 2021-12-02

Lectures

Phase 1 Study of the IDH1m Inhibitor FT-2102 As a Single Agent in Patients with IDH1m Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
FT-2102, an IDH1m Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Ayndrome (MDS): Results from a Phase 1 Study
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
IDH2 Mutations Induce Altered STAT Signaling and Cytokine Responses Which Are Restored By Enasidenib
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018